Role of PTH, Metabolic Factors and Other Hormones in Extra-Renal Acid Buffering

  • Neil A. Kurtzman
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 151)


The maintenance of normal acid-base homeostasis is dependent on the renal excretion of acid (as well as the reclamation of bicarbonate) and extra-renal buffering of acid which originates either from normal metabolism or from exogenous sources. The factors influencing renal acid excretion have been well studied. Those events which control the buffering of an acid load are less completely understood (1). Since it is believed that the skeleton is a major source of buffer, events which influence the metabolism of bone may have a profound effect on extra-renal buffering. Fraley and Adler, as well as our own group, have demonstrated that parathyroid hormone (PTH) plays a major role in the buffering of acute acid loads (2,3). More recently we have had the opportunity to study the effects of a number of other hormonal and metabolic factors which influence extra-renal buffering (4). This paper reviews our work; it examines the effect of PTH and other metabolic regulators on extra-renal buffering.


Parathyroid Hormone Chronic Renal Failure Carbonic Anhydrase Salmon Calcitonin Acid Load 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    N. Brautbar, Extrarenal factors in the homeostasis of acid-base balance, Seminars Nephrol., 1:232, (1981).Google Scholar
  2. 2.
    D.S. Fraley, and S. Adler, An extrarenal role for parathyroid hormone in the disposal of acute acid loads in rats and dogs, J. Clin. Invest., 63:985 (1979).PubMedCrossRefGoogle Scholar
  3. 3.
    J.A.L. Arruda, V. Alla, H. Rubinstein, M. Cruz-Soto, S. Sabatini, D.C. Batlle, and N.A. Kurtzman, Parathyroid hormone and extrarenal acid buffering, Am. J. Physiol., 239:F533 (1980).PubMedGoogle Scholar
  4. 4.
    V. Alla, H. Rubenstein, M. Cruz-Soto, S. Sabatini, D.C. Batlle, J.A.L. Arruda, and N.A. Kurtzman, Metabolic and hormonal factors influencing extrarenal buffering of an acute acid load, Clin. Res., 28:434A (1980).Google Scholar
  5. 5.
    D.A. Heath, J.S. Palmer, and G.D. Aurbach, The hypocalcemic action of colchicine, Endocrinology, 90:1589 (1972).PubMedCrossRefGoogle Scholar
  6. 6.
    C.V. Gay and W.J. Mueller, Carbonic anhydrase and osteoclasts: localization by labeled inhibitor autoradiography, Science, 183:432 (1974).PubMedCrossRefGoogle Scholar
  7. 7.
    J. Chanard, R. Black, M. Purkerson, J. Lewis, S. Klahr, and E. Slatopolsky, The effects of colchicine and vinblastine on parathyroid hormone secretion in the rat, Endocrinology, 101:1792 (1977).PubMedCrossRefGoogle Scholar
  8. 8.
    C. Minkin and J. Jennings, Carbonic anhydrase and bone remodeling: sulfonamide inhibition of bone resorption in organ culture, Science 176:1031 (1972).PubMedCrossRefGoogle Scholar
  9. 9.
    L.C. Waite, Carbonic anhydrase inhibitors, parathyroid hormone and calcium metabolism, Endocrinology 91:1160 (1972).PubMedCrossRefGoogle Scholar
  10. 10.
    L.C. Waite, W.A. Volkert and A.D. Kenny, Inhibition of bone resorption by acetazolamide in the rat, Endocrinology 87:1129 (1970).PubMedCrossRefGoogle Scholar
  11. 11.
    M. Emmitt, S. Goldfarb, Z.S. Agus and R.C. Narins, The pathophysiology of acid-base changes in chronically phosphate depleted rats, Bone-kidney interactions J. Clin. Invest. 59:291 (1977).CrossRefGoogle Scholar
  12. 12.
    J.A.L. Arruda, N. Julka, H. Rubenstein, S. Sabatini and N.A. Kurtzman, Distal acidification defect induced by phosphate deprivation, Metabolism 29:826 (1980).PubMedCrossRefGoogle Scholar
  13. 13.
    U. Treschel, R. Schenk, J.P. Bonjour, R.G.G. Russell, and H. Rleisch, Relation between bone mineralization, Ca absorption and plasma Ca in phosphonate-treated rats, Am. J. Physiol., 232:E298 (1977).Google Scholar
  14. 14.
    E. Slatopolsky, K. Hruska, and W.T. Rutherford, Current concepts of parathyroid hormone and vitamin D metabolism: Pertubation in chronic renal disease, Kidney Internat., 7:S70 (1975).Google Scholar
  15. 15.
    J.A.L. Arruda, S. Stipanuk, R. Walter, and N.A. Kurtzman, Effect of vasopressin administration on sodium excretion and plasma phosphate concentration, Proc. Soc. Exp. Biol. Med., 155:308 (1977).PubMedGoogle Scholar
  16. 16.
    R. Rosenbaum, A. Greenwalt, J. Lewis, S. Klahr, and E. Slatopolsky, Evidence that ADH does not increase the release of parathyroid hormone directly, Proc. Am. Soc. Nephrol., New Orleans LA, p.8 (1978).Google Scholar
  17. 17.
    M. Martinez-Maldonado, G. Eknoyan, and W.N. Suki, Natriuretic effects of vasopressin and cyclic AMP: Possible site of action in the nephron, Am. J. Physiol., 220:2013 (1971).PubMedGoogle Scholar
  18. 18.
    N.A. Kurtzman, P.W. Rogers, S. Boonjarren, and J.A.L. Arruda, Effect of infusion of pharmacologic amounts of vasopressin on renal electrolyte excretion, Am. J. Physiol., 228:890 (1977).Google Scholar
  19. 19.
    H. Rasmussen, C. Anast, and C. Arnaud, Thyrocalcitonin, EGTA and urinary electrolyte excretion, J. Clin. Invest. 46:746 (1967).PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1982

Authors and Affiliations

  • Neil A. Kurtzman
    • 1
  1. 1.Section of NephrologyUniversity of Illinois College of MedicineChicagoUSA

Personalised recommendations